ProQR seeking Clinical Trial Participants
Usher Syndrome Coalition announces partnership with ProQR to support clinical trial enrollment for a potential therapy for USH2A.
top of page
Search
- Dec 21, 2021
First patients dosed in phase 2/3 gene therapy trial for retinitis pigmentosa
The first patients have been dosed in the phase 2/3 Sirius and Celeste clinical trials investigating QR-421a in patients with USH2A.
- May 24, 2021
Clinical Trial News: Positive results in Usher syndrome and RP clinical study
ProQR news – Positive results achieved in our ongoing Usher syndrome and retinitis pigmentosa research.
All Posts
bottom of page